Weiyang Liu

1PUBLICATIONS
1CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 04, 2024
Efficacy and safety of olverembatinib in adult BCR::ABL1-positive ALL with T315I mutation or relapsed/refractory disease.

Weiyang Liu, Cheng Wang, Wanyan Ouyang

Pageof 1

Frequent Collaborators